Selenium status in elderly: Relation to cognitive decline

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 4, 2014, Pages 422-426

  Rita Cardoso, Bárbara ^a   Silva Bandeira, VerÔnica ^a   Jacob Filho, Wilson ^a   Franciscato Cozzolino, Silvia Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Cognitive decline; Mild cognitive impairment; Oxidative stress; Selenium

Indexed keywords

SELENIUM;

AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; BRAZIL NUT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FOOD COMPOSITION; HUMAN; LIFE EXPECTANCY; LIPID PEROXIDATION; MALE; MILD COGNITIVE IMPAIRMENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; SELENIUM DEFICIENCY; TEMPORAL CORTEX; VERY ELDERLY;

EID: 84940164446     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.08.009     Document Type: Article

References (50)

1. Santos K.A., Koszuoski R., Dias-da-Costa J.S., Pattussi M.P. Factors associated with functional incapacity among the elderly in Guatambu, Santa Catarina State, Brazil. Cad Saúde Pública 2007, 23(11):2781-2788.
2. Lin P., Neumann P.J. The economics of mild cognitive impairment. Alzheimer's Dement 2013, 9:58-62.
3. Schwam E.M., Abu-Shakra S., del Valle M., Townsend R.J., Carrillo M.C., Fillit H. Health economics and the value of therapy in Alzheimer's disease. Alzheimer's Dement 2007, 3:143-151.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, Washington, DC. 5th ed.
5. Luck T., Luppa M., Briel S., Riedel-Heller S.G. Incidence of mild cognitive impairment: a systematic review. Dement Geriatr Cogn Disord 2010, 29:164-175.
6. Stephan B.C., Kurth T., Matthews F.E., Brayne C., Dufouil C. Dementia risk prediction in the population: are screening models accurate?. Nat Rev Neurol 2010, 6(6):318-326.
7. Mitchell A.J., Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009, 119(4):252-265.
8. Steele M., Stuchbury G., Munch G. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol 2007, 42(1-2):28-36.
9. Norton M.C., Dew J., Smith H., Fauth E., Piercy K.W., Breitner J.C., For Cache County Investigators, et al. Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache county study. J Am Geriatr Soc 2012, 60(3):405-412.
10. Mayeux R., Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2012, 2(8):1-26.
11. Lovell M.A., Markesbery W.R. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol 2001, 58:392-396.
12. Chauhan V., Chauhan A. Oxidative stress in Alzheimer's disease. Pathophysiology 2006, 13(3):195-208.
13. Crouch P.J., Harding S.M., White A.R., Camakaris J., Bush A.I., Masters C.L. Mechanisms of Ab mediated neurodegeneration in Alzheimer's disease. Int J Biochem Cell Biol 2008, 40:181-198.
14. Cui K., Luo X., Xu K., Ven Murthy M.R. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28(5):771-799.
15. Zhu X., Lee H., Perry G., Smith M.A. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 2007, 4(1772):494-502.
16. Chen J., Berry M.J. Selenium and selenoproteins in the brain and brain diseases. J Neurochem 2003, 86:1-12.
17. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legrain S., et al. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type - place of the extracellular glutathione peroxidase. Free Radic Biol Med 1996, 20:579-587.
18. Berr C., Balansard B., Arnaud J., Roussel A.M., Alpérovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study - Etude du Vieillissement Artériel. J Am Geriatr Soc 2000, 48:1285-1291.
19. Gao S., Jin Y., Hall K.S., Liang C., Unverzagt F.W., Ji R., et al. Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol 2007, 165:955-965.
20. Cardoso B.R., Ong T.P., Jacob-Filho W., Jaluul O., Freitas M.I.A., Cozzolino S.M.F. Nutritional status of selenium in Alzheimer's disease patients. Br J Nutr 2010, 103(6):803-806.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
22. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 256(3):240-246.
23. Ferreira K.S., Gomes J.C., Bellato C.R., Jordão C.P. Concentrações de selênio em alimentos consumidos no Brasil. Rev Panam Salud Publica 2002, 11:172-177.
24. Hao D.Q., Xie G.H., Zhang Y.M., Tian G.J. Determination of serum selenium by hydride generation flame atomic absorption spectrometry. Talanta 1996, 43:595-600.
25. Willet W.C. Nutritional epidemiology 1998, Oxford University Press, New York. 2nd ed.
26. Spaccavento S., Del Prete M., Craca A., Fiore P. Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease. Arch Gerontol Geriatr 2009, 48:356-360.
27. Gillette-Guyonnet S., Nourhashemi F., Andrieu S., de Glisezinski I., Ousset P.J., Riviere D., et al. Weight loss in Alzheimer disease. Clin Nutr 2000, 71:637S-642S.
28. Wang P.N., Yang C.L., Lin K.N., Chen W.T., Chwang L.C., Liu H.C. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease: a controlled study. J Neurol 2004, 251:314-323.
29. IOM - Institute of Medicine Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids 2002, The National Academy Press, Washington, DC.
30. Lymbury R., Tinggi U., Griffiths L., Rosenfeldt F., Perkins A.V. Selenium status of the Australian population: effect of age, gender and cardiovascular disease. Biol Trace Elem Res 2008, 126(Suppl. 1):S1-S10.
31. Shaltout A.A., Castilho I.N., Welz B., Carasek E., Martens I.B., Martens A., et al. Method development and optimization for the determination of selenium in bean and soil samples using hydride generation electrothermal atomic absorption spectrometry. Talanta 2011, 85(3):1350-1356.
32. Boaventura G.T. Avaliação nutricional relativa ao selênio de estudantes da Faculdade de Ciências Farmacêuticas da USP 1994, [PhD thesis], University of São Paulo.
33. Medeiros C.S.C. Efeito da suplementação de selênio em pacientes com síndrome do intestino curto submetidos à nutrição parenteral domiciliar 1997, [Master's thesis], University of São Paulo.
34. Thomson C.D. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 2004, 58:391-402.
35. de la Monte S.M., Tong M., Lester-Coll N., Plater M., Wands J.R. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 2006, 10:89-109.
36. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 2013, [Epub ahead print]. 10.1016/j.bbadis.2013.09.010.
37. Bellinger F.P., He Q.P., Bellinger M.T., Lin Y., Raman A.V., White L.R., et al. Association of selenoprotein P with Alzheimer's pathology in human cortex. J Alzheimers Dis 2008, 15(3):465-472.
38. Takemoto A.S., Berry M.J., Bellinger F.P. Role of selenoprotein P in Alzheimer's disease. Ethn Dis 2010, 20(Suppl. 1):S1-92-5.
39. Garcia T., Esparza J.L., Nogués M.R., Romeu M., Domingo J.L., et al. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum. Hippocampus 2009, 20:218-225.
40. Zhang S., Rocourt C., Cheng W. Selenoproteins and the aging brain. Mech Ageing Dev 2010, 131:253-260.
41. Schuessel K., Leutner S., Cairns N.J., Müller W.E., Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm 2004, 111:1167-1182.
42. Ashton K., Hooper L., Harvey L.J., Hurst R., Casgrain A., Fairweather-Tait S.J. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009, 89:2025S-2039S.
43. Finley J. Selenium accumulation in plant foods. Nutr Rev 2005, 63:196-202.
44. Behr C.S. Efeito de uma dieta enriquecida com castanha-do-Brasil (Bertholletia excelsa, L.) no estado nutricional relativo ao selênio de idosos não institucionalizados 2004, [Master's thesis], University of São Paulo.
45. Bodó E.T., Stefánka Z., Ipolyi I., Sörös C., Dernovics M., Fodor P. Preparation, homogeneity and stability studies of a candidate LRM for Se speciation. Anal Bioanal Chem 2003, 377:32-38.
46. da Silva E.G., Mataveli L.R.V., Arruda M.A.Z. Speciation analysis of selenium in plankton, Brazil nut and human urine samples by HPLC-ICP-MS. Talanta 2013, 110:53-57.
47. Pires L.V., Silva A.M.O., Alencar L.L., Pimentel J.A.C., Mancini-Filho J., Cozzolino S.M.F. Investigação da concentração de selênio e dos compostos fenólicos presentes na castanha-do-brasil (Bertholletia excelsa H.B.K.) e sua atividade antioxidante in vitro. Nutrire - J Braz Soc Food Nutr 2011, 36s:7s.
48. Cominetti C., de Bortoli M.C., Purgatto E., Ong T.P., Moreno F.S., Garrido A.B., et al. Associations between glutathione peroxidase-1 Pro198Leu polymorphism, selenium status, and DNA damage levels in obese women after consumption of Brazil nuts. Nutrition 2011, 9:891-896.
49. Stockler-Pinto M.B., Mafra D., Farage N.E., Boaventura G.T., Cozzolino S.M. Effect of Brazil nut supplementation on the blood levels of selenium and glutathione peroxidase in hemodialysis patients. Nutrition 2010, 26(11-12):1065-1069.
50. Stockler-Pinto M.B., Mafra D., Moraes C., Lobo J., Boaventura G.T., Farage N.E., et al. Brazil nut (Bertholletia excelsa H.B.K.) improves oxidative stress and inflammation biomarkers in hemodialysis patients. Biol Trace Elem Res 2014, 158(1):105-112.